LENZ Therapeutics, Inc. — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Graphite Bio, Inc. (GRPH)
CIK: 0001815776
Period of Report: 2021-06-29

Reporting Person: Samsara BioCapital, L.P. (10% Owner)
Reporting Person: 436, L.P. (10% Owner)
Reporting Person: AKKARAJU SRINIVAS (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-29	Common Stock	C	6167763	—	Acquired	6167763	Indirect
2021-06-29	Common Stock	C	741107	—	Acquired	6908870	Indirect
2021-06-29	Common Stock	C	22753	—	Acquired	22753	Indirect
2021-06-29	Common Stock	P	485000	$17.00	Acquired	7393870	Indirect
2021-06-29	Common Stock	P	15000	$17.00	Acquired	37753	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-29	Series A Redeemable Convertible Preferred Stock	$	C	15000000	Disposed		Common Stock (6167763)	Indirect
2021-06-29	Series B Redeemable Convertible Preferred Stock	$	C	1802372	Disposed		Common Stock (741107)	Indirect
2021-06-29	Series B Redeemable Convertible Preferred Stock	$	C	55336	Disposed		Common Stock (22753)	Indirect

Footnotes

F1: Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a one-for-2.432 basis, and had no expiration date.

F2: Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.

F3: Shares held by 436, L.P. ("436 LP"). 436, LLC ("436 LLC") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.